Liquid Tamoxifen To Be Launched By Cytogen In Third Quarter
This article was originally published in The Pink Sheet Daily
Executive Summary
Cytogen signs an exclusive distribution agreement with manufacturer Savient.
You may also be interested in...
Zometa Plus Quadramet, Metastron For Bone Tumors Subject Of NCI-Funded Study
Study will evaluate whether a radionucleotide plus a bisphosphonate can treat metastases caused by lung, breast, prostate cancer.
Zometa Plus Quadramet, Metastron For Bone Tumors Subject Of NCI-Funded Study
Study will evaluate whether a radionucleotide plus a bisphosphonate can treat metastases caused by lung, breast, prostate cancer.
Savient’s Liquid Tamoxifen Soltamox Gets FDA Approval
Firm is seeking potential partners to market the first oral solution formulation of the breast cancer drug.